PatientsVille.com Logo

Ribavirin Side Effects

PatientsVille

Common Ribavirin Side Effects


The most commonly reported Ribavirin side effects (click to view or check a box to report):

Anaemia (736)
Fatigue (442)
Rash (391)
Nausea (391)
Pruritus (241)
Dyspnoea (205)
Vomiting (199)
Headache (186)
Decreased Appetite (176)
Haemoglobin Decreased (173)
Diarrhoea (173)
Pyrexia (172)
Depression (170)
Asthenia (168)
Insomnia (144)
Weight Decreased (138)
Dizziness (137)
White Blood Cell Count Decreased (137)
Malaise (114)
Thrombocytopenia (114)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Ribavirin Side Effects Reported to FDA



Ribavirin Side Effect Report#9999072
Hyperlipasaemia
This is a report of a 48-year-old female patient (weight: NA) from CA, suffering from the following health symptoms/conditions: NA, who was treated with Ribavirin (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Hyperlipasaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in female patients, resulting in Hyperlipasaemia side effect.
Ribavirin Side Effect Report#9995465
Cardiomyopathy, Hyperthyroidism, Thyroiditis, Hypothyroidism, Anaemia, Leukopenia, Hypocholesterolaemia, Chest Pain, Palpitations
This report suggests a potential Ribavirin (ribavirin) Cardiomyopathy side effect(s) that can have serious consequences. A 47-year-old female patient (weight: NA) from RO was diagnosed with the following symptoms/conditions: chronic hepatitis c and used Ribavirin (ribavirin) (dosage: NA) starting NS. After starting Ribavirin (ribavirin) the patient began experiencing various side effects, including: Cardiomyopathy, Hyperthyroidism, Thyroiditis, Hypothyroidism, Anaemia, Leukopenia, Hypocholesterolaemia, Chest Pain, PalpitationsAdditional drugs used concurrently:
  • Pegylated Interferon Alfa-2a (pegylated Interferon Alfa-2a)
The patient was hospitalized. Although Ribavirin (ribavirin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cardiomyopathy, may still occur.
Ribavirin Side Effect Report#9994680
Haemolytic Anaemia, Splenic Vein Thrombosis, Liver Abscess, Sepsis, Pleural Effusion, Hepatic Necrosis, Enterococcal Infection, Melaena, Renal Failure Acute
This Haemolytic Anaemia problem was reported by a consumer or non-health professional from US. A 62-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 11, 2013 this consumer started treatment with Ribavirin (ribavirin) (dosage: NA). The following drugs were being taken at the same time:
  • Sof/ldv (sofosbuvir, Ledipasvir)
  • Microfungin
  • Lisinopril/ Hctz (lisinopril, Hydrochlorothiazide)
  • Oxycodone
  • Zosyn (piperacillin Sodium, Tazobactam Sodium)
  • Albumin
  • Aspirin (acetylsalicylic Acid)
  • Packed Red Blood Cells (packed Red Blood Cells)
When using Ribavirin (ribavirin), the patient experienced the following unwanted symptoms/side effects: Haemolytic Anaemia, Splenic Vein Thrombosis, Liver Abscess, Sepsis, Pleural Effusion, Hepatic Necrosis, Enterococcal Infection, Melaena, Renal Failure AcuteThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Haemolytic Anaemia, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9994315
Psychotic Disorder, Paranoia, Hallucination, Auditory, Suicidal Ideation, Condition Aggravated, Activities Of Daily Living Impaired
This Psychotic Disorder side effect was reported by a health professional from AU. A 37-year-old female patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Ribavirin (drug dosage: NA), which was initiated on
Aug 13, 2013. Concurrently used drugs:
  • Peginterferon Alfa-2b
  • Benztropine Mesylate
  • Diazepam
  • Endep
  • Haloperidol
.After starting to take Ribavirin the consumer reported adverse symptoms, such as: Psychotic Disorder, Paranoia, Hallucination, Auditory, Suicidal Ideation, Condition Aggravated, Activities Of Daily Living ImpairedThese side effects may potentially be related to Ribavirin. The patient was hospitalized.
Ribavirin Side Effect Report#9993360
Splenic Vein Thrombosis, Liver Abscess, Sepsis, Haemolytic Anaemia
This is a report of a 62-year-old male patient (weight: NA) from Country Not Specified, suffering from the following health symptoms/conditions: NA, who was treated with Ribavirin (dosage: NA, start time: 200805), combined with:
  • Sof/ldv (sofosbuvir, Ledipasvir)
  • Spironolactone
  • Spironolactone
  • Microfungin
  • Microfungin
  • Lisinopril/hctz
  • Oxycodone
  • Zosyn
and developed a serious reaction and side effect(s): Splenic Vein Thrombosis, Liver Abscess, Sepsis, Haemolytic Anaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in male patients, resulting in Splenic Vein Thrombosis side effect. The patient was hospitalized.
Ribavirin Side Effect Report#9991798
Anaemia, Virologic Failure
This report suggests a potential Ribavirin Anaemia side effect(s) that can have serious consequences. A 53-year-old male patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: hepatitis c and used Ribavirin (dosage: 1000 Milligram Daily;) starting NS. After starting Ribavirin the patient began experiencing various side effects, including: Anaemia, Virologic FailureAdditional drugs used concurrently:
  • Ciclosporin
  • Mycophenolate Mofetil
  • Telaprevir
  • Peginterferon Alfa-2a (180 Microg)
  • Steroids
Although Ribavirin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anaemia, may still occur.
Ribavirin Side Effect Report#9991731
Anaemia, Disease Recurrence
This Anaemia problem was reported by a physician from DE. A 59-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hepatitis c. On NS this consumer started treatment with Ribavirin (dosage: 600 Milligram Daily;). The following drugs were being taken at the same time:
  • Ciclosporin
  • Mycophenolate Mofetil
  • Telaprevir
  • Peginterferon Alfa-2a (180 Microg)
  • Steroids
When using Ribavirin, the patient experienced the following unwanted symptoms/side effects: Anaemia, Disease RecurrenceAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Anaemia, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9988743
Anaemia, Blood Creatinine Increased
This Anaemia side effect was reported by a health professional from GB. A 63-year-old male patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Ribavirin (ribavirin) (drug dosage: NA), which was initiated on
Nov 07, 2012. Concurrently used drugs:
  • Telaprevir (telaprevir)
  • Lisinopril (lisinopril)
  • Peginterferon Alfa-2b (peginterferon Alfa-2b)
.After starting to take Ribavirin (ribavirin) the consumer reported adverse symptoms, such as: Anaemia, Blood Creatinine IncreasedThese side effects may potentially be related to Ribavirin (ribavirin).
Ribavirin Side Effect Report#9988705
Fatigue, Hallucination, Headache, Irritability, Mood Swings, Rash, Rash Pruritic, Depression, Anxiety
This is a report of a 52-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: hepatitis c, who was treated with Ribavirin (dosage: NA, start time:
Oct 08, 2012), combined with:
  • Interferon Alfa-2a
  • Incivo (telaprevir)
  • Peginterferon Alfa-2b
and developed a serious reaction and side effect(s): Fatigue, Hallucination, Headache, Irritability, Mood Swings, Rash, Rash Pruritic, Depression, Anxiety after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in male patients, resulting in Fatigue side effect.
Ribavirin Side Effect Report#9982067
Headache, Nausea, Visual Impairment, Refusal Of Treatment By Patient
This report suggests a potential Ribavirin 200mg Zydus Pharmaceuticals Headache side effect(s) that can have serious consequences. A 47-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic hepatitis c and used Ribavirin 200mg Zydus Pharmaceuticals (dosage: NA) starting
Feb 06, 2014. After starting Ribavirin 200mg Zydus Pharmaceuticals the patient began experiencing various side effects, including: Headache, Nausea, Visual Impairment, Refusal Of Treatment By PatientAdditional drugs used concurrently:
  • Sovaldi 400mg Gilead Sciences
Although Ribavirin 200mg Zydus Pharmaceuticals demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Headache, may still occur.
Ribavirin Side Effect Report#9981257
Oesophageal Tuberculosis, Leukopenia, Immune System Disorder
This Oesophageal Tuberculosis problem was reported by a health professional from US. A 42-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic hepatitis c. On NS this consumer started treatment with Ribavirin (ribavirin) (dosage: NA). The following drugs were being taken at the same time:
  • Peginterferon Alfa-2a (peginterferon Alfa-2a)
When using Ribavirin (ribavirin), the patient experienced the following unwanted symptoms/side effects: Oesophageal Tuberculosis, Leukopenia, Immune System DisorderAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Oesophageal Tuberculosis, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9980608
Pancytopenia, Alopecia Universalis
This Pancytopenia side effect was reported by a health professional from IT. A 49-year-old male patient (weight:NA) experienced the following symptoms/conditions: chronic hepatitis c.The patient was prescribed Ribavirin (drug dosage: 1200 Mg Daily), which was initiated on NS. Concurrently used drugs:
  • Peginterferon Alfa-2b
.After starting to take Ribavirin the consumer reported adverse symptoms, such as: Pancytopenia, Alopecia UniversalisThese side effects may potentially be related to Ribavirin.
Ribavirin Side Effect Report#9973668
Stress Cardiomyopathy, Chest Pain, Dyspnoea, Palpitations, Hyperhidrosis, Fatigue, Hypocholesterolaemia, Hepatic Enzyme Increased, Ventricular Hypokinesia
This is a report of a 47-year-old female patient (weight: NA) from RO, suffering from the following health symptoms/conditions: chronic hepatitis c, who was treated with Ribavirin (dosage: 1000 Mg/day, start time: NS), combined with:
  • Pegylated Interferon Alfa-2a (180 Ug Per Week)
and developed a serious reaction and side effect(s): Stress Cardiomyopathy, Chest Pain, Dyspnoea, Palpitations, Hyperhidrosis, Fatigue, Hypocholesterolaemia, Hepatic Enzyme Increased, Ventricular Hypokinesia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in female patients, resulting in Stress Cardiomyopathy side effect. The patient was hospitalized.
Ribavirin Side Effect Report#9973649
Creatinine Renal Clearance Increased, Rash
This report suggests a potential Ribavirin Creatinine Renal Clearance Increased side effect(s) that can have serious consequences. A 68-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: NA and used Ribavirin (dosage: 400 Mg, Qd) starting
Nov 04, 2013. After starting Ribavirin the patient began experiencing various side effects, including: Creatinine Renal Clearance Increased, RashAdditional drugs used concurrently:
  • Pegylated Interferon Alfa-2a (180 Ug, Qw)
  • Telaprevir (2250 Mg, Qd)
Although Ribavirin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Creatinine Renal Clearance Increased, may still occur.
Ribavirin Side Effect Report#9971688
Clostridium Difficile Infection, Escherichia Urinary Tract Infection, Gastroenteritis Rotavirus
This Clostridium Difficile Infection problem was reported by a health professional from DE. A 62-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hepatitis c. On NS this consumer started treatment with Ribavirin (ribavirin) (dosage: NA). The following drugs were being taken at the same time:
  • Peginterferon (peginterferon)
  • Telaprevir (telaprevir)
When using Ribavirin (ribavirin), the patient experienced the following unwanted symptoms/side effects: Clostridium Difficile Infection, Escherichia Urinary Tract Infection, Gastroenteritis RotavirusAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Clostridium Difficile Infection, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9971673
Infection, Viral Infection
This Infection side effect was reported by a health professional from DE. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Ribavirin (ribavirin) (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Peginterferon (peginterferon)
  • Telaprevir (telaprevir)
.After starting to take Ribavirin (ribavirin) the consumer reported adverse symptoms, such as: Infection, Viral InfectionThese side effects may potentially be related to Ribavirin (ribavirin).
Ribavirin Side Effect Report#9971657
Yersinia Infection, Gastroenteritis Norovirus, Gastroenteritis Clostridial, Gastroenteritis Bacterial, Proteus Infection, Urinary Tract Infection Bacterial
This is a report of a 58-year-old male patient (weight: NA) from DE, suffering from the following health symptoms/conditions: hepatitis c, who was treated with Ribavirin (dosage: NA, start time: NS), combined with:
  • Peginterferon (peginterferon)
  • Telaprevir (telaprevir)
and developed a serious reaction and side effect(s): Yersinia Infection, Gastroenteritis Norovirus, Gastroenteritis Clostridial, Gastroenteritis Bacterial, Proteus Infection, Urinary Tract Infection Bacterial after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in male patients, resulting in Yersinia Infection side effect.
Ribavirin Side Effect Report#9971636
H1n1 Influenza, Klebsiella Infection, Urinary Tract Infection Bacterial, Oral Herpes, Cytomegalovirus Enteritis
This report suggests a potential Ribavirin (ribavirin) H1n1 Influenza side effect(s) that can have serious consequences. A 66-year-old female patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: hepatitis c and used Ribavirin (ribavirin) (dosage: NA) starting NS. After starting Ribavirin (ribavirin) the patient began experiencing various side effects, including: H1n1 Influenza, Klebsiella Infection, Urinary Tract Infection Bacterial, Oral Herpes, Cytomegalovirus EnteritisAdditional drugs used concurrently:
  • Peginterferon (peginterferon)
Although Ribavirin (ribavirin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as H1n1 Influenza, may still occur.
Ribavirin Side Effect Report#9971619
No Therapeutic Response
This No Therapeutic Response problem was reported by a health professional from DE. A 53-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hepatitis c. On NS this consumer started treatment with Ribavirin (dosage: NA). The following drugs were being taken at the same time:
  • Peginterferon
  • Telaprevir
When using Ribavirin, the patient experienced the following unwanted symptoms/side effects: No Therapeutic ResponseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as No Therapeutic Response, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9971587
Pneumonia Bacterial
This Pneumonia Bacterial side effect was reported by a health professional from DE. A 51-year-old male patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Ribavirin (ribavirin) (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Peginterferon Alpha
  • Telaprevir (telaprevir)
.After starting to take Ribavirin (ribavirin) the consumer reported adverse symptoms, such as: Pneumonia BacterialThese side effects may potentially be related to Ribavirin (ribavirin).
Ribavirin Side Effect Report#9970167
Viral Infection
This is a report of a 53-year-old male patient (weight: NA) from DE, suffering from the following health symptoms/conditions: hepatitis c, who was treated with Ribavirin (dosage: NA, start time: NS), combined with:
  • Peginterferon
  • Telaprevir
and developed a serious reaction and side effect(s): Viral Infection after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin treatment in male patients, resulting in Viral Infection side effect.
Ribavirin Side Effect Report#9969766
Anaemia, Leukopenia, Treatment Failure, Pneumonia Bacterial, Haematotoxicity
This report suggests a potential Ribavirin(ribavirin) Anaemia side effect(s) that can have serious consequences. A 58-year-old male patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: hepatitis c,hepatitis cholestatic and used Ribavirin(ribavirin) (dosage: 1000 Mg/day (at Baseline, Week 4 And 8)) starting NS. After starting Ribavirin(ribavirin) the patient began experiencing various side effects, including: Anaemia, Leukopenia, Treatment Failure, Pneumonia Bacterial, HaematotoxicityAdditional drugs used concurrently: NA. Although Ribavirin(ribavirin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anaemia, may still occur.
Ribavirin Side Effect Report#9969622
Hyperthyroidism, Stress Cardiomyopathy
This Hyperthyroidism problem was reported by a health professional from RO. A 47-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic hepatitis c. On NS this consumer started treatment with Ribavirin (dosage: NA). The following drugs were being taken at the same time:
  • Peg-interferon Alfa 2a
When using Ribavirin, the patient experienced the following unwanted symptoms/side effects: Hyperthyroidism, Stress CardiomyopathyThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hyperthyroidism, may become evident only after a product is in use by the general population.
Ribavirin Side Effect Report#9960856
Tremor, Palpitations
This Tremor side effect was reported by a pharmacist from US. A 62-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Ribavirin (drug dosage: NA), which was initiated on 201402. Concurrently used drugs: NA..After starting to take Ribavirin the consumer reported adverse symptoms, such as: Tremor, PalpitationsThese side effects may potentially be related to Ribavirin.
Ribavirin Side Effect Report#9958838
Convulsion
This is a report of a 36-year-old male patient (weight: NA) from IT, suffering from the following health symptoms/conditions: chronic hepatitis c, who was treated with Ribavirin (ribavirin) (dosage: NA, start time: NS), combined with:
  • Peginterferon Alfa-2a (peginterferon Alfa-2a) (180 Microg Weekly)
  • Telaprevir (telaprevir) (750 Mg Three Times Per Day)
  • Escitalopram (escitalopram) (10mg/day)
and developed a serious reaction and side effect(s): Convulsion after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ribavirin (ribavirin) treatment in male patients, resulting in Convulsion side effect.


1 of 156 


The appearance of Ribavirin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Ribavirin Side Effects for Women?

Women Side EffectsReports
Anaemia 322
Fatigue 196
Nausea 196
Rash 150
Vomiting 109
Headache 93
Dyspnoea 92
Pruritus 91
Depression 77
Diarrhoea 77

What are common Ribavirin Side Effects for Men?

Men Side EffectsReports
Anaemia 411
Fatigue 242
Rash 239
Nausea 190
Pruritus 149
Dyspnoea 113
Pyrexia 104
Haemoglobin Decreased 102
Decreased Appetite 99
Diarrhoea 96

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Ribavirin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Ribavirin Side Effects

    Did You Have a Ribavirin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ribavirin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Ribavirin Safety Alerts, Active Ingredients, Usage Information

    NDC0093-7227
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameRibavirin
    NameRibavirin
    Dosage FormCAPSULE
    RouteORAL
    On market since20041004
    LabelerTeva Pharmaceuticals USA Inc
    Active Ingredient(s)RIBAVIRIN
    Strength(s)200
    Unit(s)mg/1
    Pharma ClassNucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]

    Ribavirin Dosage, Warnings, Usage.

    Side Effects reported to FDA: 3887

    Ribavirin safety alerts: 2012

    Reported deaths: 174

    Reported hospitalizations: 1350

    Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions

     

    [Posted 12/19/2012]

    AUDIENCE: Internal Medicine, Gastroenterology, Dermatology

    ISSUE: FDA received reports of serious skin reactions, some fatal, in patients taking the hepatitis C drug Incivek (telaprevir) in combination with the drugs peginterferon alfa and ribavirin (Incivek combination treatment). Some patients died when they continued to receive Incivek combination treatment after developing a worsening, or progressive rash and systemic symptoms (symptoms affecting the entire body).   

    See the FDA Drug Safety Communication Data Summary section for additional information.

    FDA is adding a boxed warning to the Incivek drug label stating that Incivek combination treatment must be immediately stopped in patients experiencing a rash with systemic symptoms or a progressive severe rash.

    BACKGROUND: Incivek is a hepatic C virus NS3/4A protease inhibitor indicated in combination with peginterferon alfa and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease, including patients who have cirrhosis, are treatment-naïve, or who have been previously received interferon-based treatment.

    RECOMMENDATIONS: Make sure your patients know that rash may occur with Incivek combination treatment, and explain the signs and symptoms of severe skin reaction and when to seek care.

    If serious skin reactions occur, all three components of Incivek combination treatment, including peginterferon alfa and ribavirin, must be immediately discontinued, and the patient should receive urgent medical care. Consideration should also be given to stopping any other medications that may be associated with serious skin reactions.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [12/19/2012 - Drug Safety Communication - FDA]

    Latest Ribavirin clinical trials